Assessment of Changes in Renal Cortical and Medullary Blood Flow by Contrast Ultrasound

University of Virginia1 site in 1 country20 target enrollmentJune 2006

ConditionsKidney

Drugsperflutren lipid microspheres

Overview

Phase: N/A
Intervention: Not specified
Conditions: Kidney
Sponsor: University of Virginia
Enrollment: 20
Locations: 1
Last Updated: 17 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to determine if contrast enhanced ultrasound (CEU) using microbubbles, is useful in assessing changes in kidney blood flow.

Registry

clinicaltrials.gov

Start Date

June 2006

End Date

December 2009

Last Updated

17 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

University of Virginia

Eligibility Criteria

Inclusion Criteria

•Healthy adults
•Males and females
•Ages 18-65 years old

Exclusion Criteria

•Pregnancy or lactation
•H/o kidney disease
•H/o congestive heart failure, ischemic heart disease, severe pulmonary disease or allergy to the drug
•H/o any cardiovascular disease
•Abnormal liver function (liver function tests out of specified ranges)
•Screening urinalysis which indicates infection or inflammation
•Taking regular medications (except for over-the-counter vitamins or hormonal contraceptives.)
•Taking supplements, like protein shakes
•Unwilling or unable to eat chicken (used as protein meal)